Reduction of infarct size. An attractive concept: useful--or possible--in humans?
D000693:Anaerobiosis / Q000187:drug effects; D000818:Animals; D004734:Energy Metabolism / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006019:Glycolysis / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D010477:Perfusion
D005343:Fibrinolytic Agents; D010100:Oxygen